Difference between revisions of "Rotation: Breast"
From MGH Learn Pathology
| Line 19: | Line 19: | ||
# [[Breast:_Radiology-Pathology_Correlation_on_Core_Biopsy|Radiologic Correlation]] | # [[Breast:_Radiology-Pathology_Correlation_on_Core_Biopsy|Radiologic Correlation]] | ||
<br> | <br> | ||
| − | + | Weeks 2 & 3 | |
# [[Breast:_Grading_Invasive_Carcinoma|Grading Invasive Carcinoma]] | # [[Breast:_Grading_Invasive_Carcinoma|Grading Invasive Carcinoma]] | ||
# [[Breast:_Grading_Ductal_Carcinoma_In-situ|Grading Ductal Carcinoma In-situ]] | # [[Breast:_Grading_Ductal_Carcinoma_In-situ|Grading Ductal Carcinoma In-situ]] | ||
# [[Breast:_Staging_of_Breast_Cancer|Staging of Breast Cancer]] | # [[Breast:_Staging_of_Breast_Cancer|Staging of Breast Cancer]] | ||
| − | + | Weeks 4 & 5 | |
| − | |||
# [[Breast:_Immunohistochemistry_in_Breast_Pathology|Immunohistochemistry in Breast Pathology]] | # [[Breast:_Immunohistochemistry_in_Breast_Pathology|Immunohistochemistry in Breast Pathology]] | ||
# [[Breast:_Treatment_of_Breast_Cancer|Treatment of Breast Cancer]] | # [[Breast:_Treatment_of_Breast_Cancer|Treatment of Breast Cancer]] | ||
| − | |||
== Diagnostic Entities == | == Diagnostic Entities == | ||
<bootstrap_collapse text="Weeks 2 & 3"><p> | <bootstrap_collapse text="Weeks 2 & 3"><p> | ||
Revision as of 19:27, August 27, 2019
Contents
Breast Rotation Overview
- Rotation Overview
- Introduction
- Daily Activities
- Before your begin...
- At the grossing bench
- Prior to Signout (Previewing)
Sign Out Tools
Technical Grossing Manual
Didactics
Week 1
Weeks 2 & 3
Weeks 4 & 5
Diagnostic Entities
- Blunt Duct Adenosis
- Ductal Carcinoma In-situ (DCIS)
- Fibroadenoma (FBA)
- Fibrocystic Changes (FCC)
- Hamartoma
- Invasive Ductal Carcinoma (IDC)
- Invasive Lobular Carcinoma (ILC)
- Invasive Mucinous Carcinoma
- Lobular Carcinoma In-situ (LCIS)
- Papilloma
- Radial Scar
- Sclerosing Adenosis
- Tubular Carcinoma
- Usual Ductal Hyperplasia (UDH)
- Adenoid Cystic Carcinoma
- Atypical Ductal Hyperplasia (ADH)
- Atypical Lobular Hyperplasia (ALH)
- Angiosarcoma
- Endocrine Carcinoma
- Fibromatosis
- Flat Epithelial Atypia (FEA)
- Medullary Carcinoma
- Metaplastic Carcinoma
- Mucocele-like Lesion
- Myofibroblastoma
- Myxoid Fibroadenoma
- Paget Disease
- Papillary Carcinoma
- Phyllodes Tumor
- Pleomorphic Lobular Carcinoma In-situ
- Pseudoangiomatous Stromal Hyperplasia (PASH)
- Radiation Changes
- Secretory Carcinoma
